{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:04:36Z","timestamp":1789632276419,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Cancer Center Research and Development Fund","award":["2024-A-17"],"award-info":[{"award-number":["2024-A-17"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the availability of effective interventions for cancer prevention, Japan faces substantial evidence\u2013practice gaps, such as in the low utilization of smoking cessation treatments, HPV vaccination, and cancer screening. Implementation research plays a critical role in bridging this gap by promoting the uptake of effective interventions in real-world settings. Globally, however, prioritization of the implementation of these various interventions remains unclear. To address this need, we conducted a structured priority-setting exercise using the CHNRI method and incorporating perspectives from diverse stakeholders, including citizens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a four-phase research prioritization process using the CHNRI method to identify which effective interventions for cancer prevention should be prioritized for implementation in Japan. The process included listing effective interventions for cancer prevention, surveying stakeholders, conducting a web-based survey among researchers, and calculating priority scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 215 invited researchers, 92 (42.8%) and 67 (31.2%) researchers responded to the first and second surveys, respectively. In both surveys, physicians accounted for the largest proportion of respondents. Across both surveys, HPV vaccination for females, cervical cancer screening, fecal occult blood testing (FOBT), mammography, and tobacco control policies were identified as top priorities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Priorities for implementing effective interventions for cancer prevention were set through collaboration with researchers and citizens, providing a foundation for future research and progress.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-16415-2","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:55:01Z","timestamp":1782806101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Priority setting for the implementation of effective interventions for cancer prevention through collaboration among patients, the public and researchers in Japan"],"prefix":"10.1186","volume":"26","author":[{"given":"Mai","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Odawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Yamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomio","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"16415_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.35772\/ghm.2021.01037","volume":"4","author":"M Inoue","year":"2022","unstructured":"Inoue M, Hirabayashi M, Abe SK, Katanoda K, Sawada N, Lin Y, et al. Burden of cancer attributable to modifiable factors in Japan in 2015. Glob Health Med. 2022;4:26\u201336.","journal-title":"Glob Health Med"},{"key":"16415_CR2","unstructured":"Bray F, Colombet M, Aitken J, Bardot A, Eser S, Galceran J et al. Cancer Incidence in Five Continents, Vol. XII (IARC CancerBase No. 19) Lyon: International Agency for Research on Cancer; 2023. https:\/\/ci5.iarc.who.int. Accessed 30 Apr 2026."},{"key":"16415_CR3","volume-title":"Health at a glance 2023: OECD indicators","author":"Organisation for Economic Co-operation and Development","year":"2023","unstructured":"Organisation for Economic Co-operation and Development. Health at a glance 2023: OECD indicators. Paris: OECD Publishing; 2023."},{"key":"16415_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-1-1","volume":"1","author":"MP Eccles","year":"2006","unstructured":"Eccles MP, Mittman BS. Welcome to implementation science. Implement Sci. 2006;1:1.","journal-title":"Implement Sci"},{"key":"16415_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40359-015-0089-9","volume":"3","author":"MS Bauer","year":"2015","unstructured":"Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM. An introduction to implementation science for the non-specialist. BMC Psychol. 2015;3:32.","journal-title":"BMC Psychol"},{"key":"16415_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13012-022-01255-y","volume":"17","author":"JN Ervin","year":"2022","unstructured":"Ervin JN, Dibble MR, Rentes VC, Sjoding MW, Gong MN, Hough CL, et al. Prioritizing evidence-based practices for acute respiratory distress syndrome using digital data: an iterative multi-stakeholder process. Implement Sci. 2022;17:82.","journal-title":"Implement Sci"},{"key":"16415_CR7","unstructured":"American Association for Cancer Research. Expert panel releases recommendations to support Cancer Moonshot initiative. 2016. https:\/\/www.aacr.org\/professionals\/policy-and-advocacy\/cancer-moonshot\/. Accessed 10 Jan 2026."},{"key":"16415_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1478-4505-8-36","volume":"8","author":"RF Viergever","year":"2010","unstructured":"Viergever RF, Olifson S, Ghaffar A, Terry RF. A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst. 2010;8:36.","journal-title":"Health Res Policy Syst"},{"key":"16415_CR9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3325\/cmj.2008.49.720","volume":"49","author":"I Rudan","year":"2008","unstructured":"Rudan I, Gibson JL, Ameratunga S, El Arifeen S, Bhutta ZA, Black M, et al. Setting priorities in global child health research investments: guidelines for implementation of CHNRI method. Croat Med J. 2008;49:720\u201333.","journal-title":"Croat Med J"},{"key":"16415_CR10","doi-asserted-by":"publisher","first-page":"011004","DOI":"10.7189\/jogh.07.011004","volume":"7","author":"I Rudan","year":"2017","unstructured":"Rudan I, Yoshida S, Chan KY, Sridhar D, Wazny K, Nair H, et al. Setting health research priorities using the CHNRI method: VII. A review of the first 50 applications of the CHNRI method. J Glob Health. 2017;7:011004.","journal-title":"J Glob Health"},{"key":"16415_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s43058-025-00725-w","volume":"6","author":"A Mathieson","year":"2025","unstructured":"Mathieson A, Brunton L, Wilson PM. The use of patient and public involvement and engagement in the design and conduct of implementation research: a scoping review. Implement Sci Commun. 2025;6:42.","journal-title":"Implement Sci Commun"},{"key":"16415_CR12","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/jjco\/hyy048","volume":"48","author":"S Sasazuki","year":"2018","unstructured":"Sasazuki S, Inoue M, Shimazu T, Wakai K, Naito M, Nagata C, et al. Evidence-based cancer prevention recommendations for Japanese. Jpn J Clin Oncol. 2018;48:576\u201386.","journal-title":"Jpn J Clin Oncol"},{"key":"16415_CR13","unstructured":"National Cancer Center Institute for Cancer Control NCC, Japan. Cancer Screening Guidelines (in Japanese). https:\/\/canscreen.ncc.go.jp\/guideline\/list.html. Accessed 30 Apr 2026."},{"issue":"4","key":"16415_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/jjco\/hyn016","volume":"38","author":"C Hamashima","year":"2008","unstructured":"Hamashima C, Saito H, Nakayama T, Nakayama T, Sobue T. The Standardized Development Method of the Japanese Guidelines for Cancer Screening. Jpn J Clin Oncol. 2008;38(4):288\u201395.","journal-title":"Jpn J Clin Oncol"},{"key":"16415_CR15","unstructured":"Ministry of Health, Labour and Welfare. Guidelines for priority health education on cancer prevention and implementation of cancer screening (in Japanese). 2025. https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-10900000-Kenkoukyoku\/0000059992.pdf. Accessed 10 Jan 2026."},{"key":"16415_CR16","unstructured":"National Cancer Center Japan. Patient-public panel (in Japanese). https:\/\/www.ncc.go.jp\/jp\/icc\/cancer-info\/panel\/index.html. Accessed 10 Jan 2026."},{"key":"16415_CR17","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1016\/S0140-6736(15)61152-7","volume":"385","author":"SJ Hanley","year":"2015","unstructured":"Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet. 2015;385:2571.","journal-title":"Lancet"},{"key":"16415_CR18","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1111\/cas.14406","volume":"111","author":"S Nakagawa","year":"2020","unstructured":"Nakagawa S, Ueda Y, Yagi A, Ikeda S, Hiramatsu K, Kimura T. Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan. Cancer Sci. 2020;111:2156\u201362.","journal-title":"Cancer Sci"},{"key":"16415_CR19","unstructured":"Ministry of Health, Labour and Welfare. About HPV vaccines (in Japanese). 2022. https:\/\/www.mhlw.go.jp\/content\/10601000\/000928721.pdf. Accessed 10 Jan 2026."},{"key":"16415_CR20","doi-asserted-by":"crossref","unstructured":"Yagi A, Ueda Y, Oka E, Nakagawa S, Kimura T. Human papillomavirus vaccination by birth fiscal year in Japan. JAMA Netw Open. 2024;7:e2422513.","DOI":"10.1001\/jamanetworkopen.2024.22513"},{"key":"16415_CR21","unstructured":"Japan Cancer Society. Survey report on HPV vaccination (in Japanese). https:\/\/www.jcancer.jp\/release\/16099. Accessed 10 Jan 2026."},{"key":"16415_CR22","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1016\/j.vaccine.2023.10.024","volume":"41","author":"M Terada","year":"2023","unstructured":"Terada M, Shimazu T, Saito J, Odawara M, Otsuki A, Yaguchi-Saito A, et al. Age, gender and socioeconomic disparities in human papillomavirus (HPV) awareness and knowledge among Japanese adults after a 7-year suspension of proactive recommendation for the HPV vaccine: a nationally representative cross-sectional survey. Vaccine. 2023;41:7147\u201358.","journal-title":"Vaccine"},{"key":"16415_CR23","unstructured":"Cancer Information Service, National Cancer Center Japan. Cancer screening rate (in Japanese). https:\/\/ganjoho.jp\/reg_stat\/statistics\/stat\/screening\/screening.html. Accessed 10 Jan 2026."},{"key":"16415_CR24","unstructured":"Ministry of Health, Labour and Welfare. Comprehensive survey of living conditions (in Japanese). 2022. https:\/\/www.mhlw.go.jp\/toukei\/list\/20-21.html. Accessed 10 Jan 2026."},{"key":"16415_CR25","volume-title":"Regional action plan for tobacco control in the Western Pacific (2020\u20132030): working towards a healthy, tobacco-free region","author":"World Health Organization Regional Office for the Western Pacific","year":"2020","unstructured":"World Health Organization Regional Office for the Western Pacific. Regional action plan for tobacco control in the Western Pacific (2020\u20132030): working towards a healthy, tobacco-free region. Manila: WHO; 2020."},{"key":"16415_CR26","doi-asserted-by":"crossref","unstructured":"Tanaka J, Kurisu A, Ko K, Sugiyama A, Akita T. Updated burden and long-term projections of chronic hepatitis B and C in Japan: a nationwide markov modeling study. Hepatol Res. 2026:1\u201312.","DOI":"10.1111\/hepr.70174"},{"issue":"9","key":"16415_CR27","doi-asserted-by":"publisher","first-page":"e70064","DOI":"10.1111\/jvh.70064","volume":"32","author":"F Green","year":"2025","unstructured":"Green F, Simmons R, Leeman D, Desai M, Hibbert M. Global Systematic Review of the Measurement of Stigma Associated With People Living With Hepatitis B or Hepatitis C Viruses. J Viral Hepat. 2025;32(9):e70064.","journal-title":"J Viral Hepat"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16415-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16415-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16415-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:24:39Z","timestamp":1789629879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16415-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16415"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16415-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The survey of the Patient-Public Panel was a preliminary investigation conducted during the preparatory stage of the study. According to the ethical guidelines of the National Cancer Center, ethical review was not required. Information about the researchers was collected solely from publicly available online sources. No personal or identifiable information was obtained through the survey, and ethical approval from the National Cancer Center was not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1108"}}